Drug reference

Atazanavir with cobicistat

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 715, 716

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

HIV infection, in combination with other antiretroviral drugs (initiated by a specialist) ▶BY MOUTH ▶Adult: 300/150 mg once daily DOSE EQUIVALENCE AND CONVERSION ▶Dose expressed as x/y mg of atazanavir/cobicistat.

PDF page 715

Contra Indications

Haemodialysis

PDF page 715

Safety

Interactions

→Appendix 1: cobicistat. HIV-protease inhibitors

PDF page 715

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Tablet CAUTIONARY AND ADVISORY LABELS 5, 21 ▶Evotaz (Bristol-Myers Squibb Pharmaceuticals Ltd) A Cobicistat 150 mg, Atazanavir (as Atazanavir sulfate) 300 mg Evotaz 300mg/150mg tablets | 30 tablet P £323.38 eiiii F 693

PDF pages 715, 716

Dose text by age group

Adult

300/150 mg once daily

First-line fragment. Read the complete Indications and Dose section above.

PDF page 715

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Atazanavir with cobicistat

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 715, 716

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

PDF page 715

Contra Indications

Haemodialysis

PDF page 715

Safety

Interactions

→Appendix 1: cobicistat. HIV-protease inhibitors

PDF page 715

Dose and formulations

Medicinal Forms

PDF pages 715, 716

Dose text by age group

Adult

300/150 mg once daily

First-line fragment. Read the complete Indications and Dose section above.

PDF page 715

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.